Management of adult patients with severe atopic dermatitis treated with dupilumab duringCOVID-19 pandemic: A single-center real-life experience

被引：17

作者：

Rossi, Mariateresa ^{[1
]}

Rovati, Chiara ^{[1
]}

Arisi, Mariachiara ^{[1
]}

Soglia, Simone ^{[1
]}

Calzavara-Pinton, Piergiacomo ^{[1
]}

机构：

[1] Univ Brescia, Dermatol Dept, ASST Spedali Civili Brescia, Brescia, Italy

来源：

DERMATOLOGIC THERAPY | 2020年 / 33卷 / 04期

关键词：

D O I：

10.1111/dth.13765

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页数：2

共 4 条

[1]

[Anonymous], 2020, BMJ BRIT MED J, DOI DOI 10.1136/BMJ.M757

[2] No evidence of increased risk for Coronavirus Disease 2019 (COVID-19) in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy [J].

Carugno, A. ;

Raponi, F. ;

Locatelli, A. G. ;

Vezzoli, P. ;

Gambini, D. M. ;

Di Mercurio, M. ;

Robustelli Test, E. ;

Sena, P. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (09) :E433-E434

[3] Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports [J].

Ferrucci, S. ;

Romagnuolo, M. ;

Angileri, L. ;

Berti, E. ;

Tavecchio, S. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (07) :E303-E304

[4] Dupilumab and COVID-19: What should we expect? [J].

Patruno, Cataldo ;

Stingeni, Luca ;

Fabbrocini, Gabriella ;

Hansel, Katharina ;

Napolitano, Maddalena .

DERMATOLOGIC THERAPY, 2020, 33 (04)

← 1 →